文献速递妇科产科生殖医学

早期卵巢癌保留生育功能手术后首次妊娠结局

Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian Cancer.
PubMed 文献 · Obstet Gynecol · 2021-01-01

该回顾性研究纳入2000-2012年加州癌症登记中18-45岁、IA或IC期卵巢癌患者,将保留生育功能手术后至少3个月妊娠者与对照按1:2倾向评分匹配,比较首次妊娠的产科结局。结果显示手术与早产、小于胎龄儿、严重孕产妇并发症及新生儿并发症风险均无显著关联。

要点

  • 保留生育功能手术后至少3个月妊娠未增加早产风险(13.7% vs 11.4%;OR 1.23,95%CI 0.69-2.20)。
  • 小于胎龄儿(<第10百分位)风险无显著差异(11.8% vs 12.7%;OR 0.91,95%CI 0.50-1.66)。
  • 严重孕产妇并发症与新生儿并发症风险均无显著升高。

核心结论

  • 早期卵巢癌保留生育功能手术后至少3个月妊娠者,未观察到不良产科结局风险增加。

研究设计与样本

  • 回顾性研究,数据来自2000-2012年加州癌症登记,并与加州规划发展办公室出生及出院数据集链接。
  • 纳入18-45岁、IA或IC期卵巢癌患者,病例组为保留生育功能手术后至少3个月妊娠者,仅分析首次妊娠。
  • 病例组153例与对照组306例按1:2倾向评分匹配,采用Wald统计量和逻辑回归评估结局。

主要发现

  • 组织学类型包括上皮性(55%)、生殖细胞(37%)和性索间质(7%)。
  • 早产(<37周)发生率病例组13.7%、对照组11.4%(OR 1.23,95%CI 0.69-2.20)。
  • 小于胎龄儿(出生体重<第10百分位)发生率11.8% vs 12.7%(OR 0.91,95%CI 0.50-1.66)。
  • 严重孕产妇并发症发生率2.6% vs 1.3%(OR 2.03,95%CI 0.50-8.25)。
  • 新生儿并发症发生率两组均为5.9%(OR 1.00,95%CI 0.44-2.28)。

关键数值与推荐

  • 主要结局为早产,仅分析癌症诊断后首次妊娠。
  • 次要结局包括小于胎龄儿、新生儿并发症(生后72小时内呼吸支持、缺氧缺血性脑病、惊厥、感染、胎粪吸入综合征、产伤、颅内或帽状腱膜下出血)及CDC定义的严重孕产妇并发症。

临床怎么用

  • 对于有早期卵巢癌保留生育功能手术史的妊娠妇女,可参考本研究结果进行产科风险评估。
  • 本研究未显示早产、小于胎龄儿、严重孕产妇并发症或新生儿并发症风险显著增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the outcomes of the first pregnancy after fertility-sparing surgery in patients treated for early-stage ovarian cancer. METHODS: We performed a retrospective study of women aged 18-45 years with a history of stage IA or IC ovarian cancer reported to the California Cancer Registry for the years 2000-2012. These data were linked to the 2000-2012 California Office of Statewide Health Planning and Development birth and discharge data sets to ascertain oncologic characteristics and obstetric outcomes. We included in the case group ovarian cancer patients who conceived at least 3 months after fertility-sparing surgery. The primary outcome was preterm birth, and only the first pregnancy after cancer diagnosis was considered. Secondary outcomes included small-for-gestational-age (SGA) neonates, neonatal morbidity (respiratory support within 72 hours after birth, hypoxic-ischemic encephalopathy, seizures, infection, meconium aspiration syndrome, birth trauma, and intracranial or subgaleal hemorrhage), and severe maternal morbidity as defined by the Centers for Disease Control and Prevention. Propensity scores were used to match women in a 1:2 ratio for the case group and the control group. Wald statistics and logistic regressions were used to evaluate outcomes. RESULTS: A total of 153 patients who conceived after fertility-sparing surgery were matched to 306 women in a control group. Histologic types included epithelial (55%), germ-cell (37%), and sex-cord stromal (7%). Treatment for ovarian cancer was not associated with preterm birth before 37 weeks of gestation (13.7% vs 11.4%; odds ratio [OR] 1.23, 95% CI 0.69-2.20), SGA neonates (birth weight less than the 10th percentile: 11.8% vs 12.7%; OR 0.91, 95% CI 0.50-1.66), severe maternal morbidity (2.6% vs 1.3%; OR 2.03, 95% CI 0.50-8.25), or neonatal morbidity (both 5.9% OR 1.00, 95% CI 0.44-2.28). CONCLUSION: Patients who conceived at least 3 months after surgery for early-stage ovarian cancer did not have an increased risk of adverse obstetric outcomes.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Nitecki R, Clapp MA, Fu S, et al. Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian Cancer. Obstet Gynecol. 2021. PMID: 33957660. doi:10.1097/AOG.0000000000004394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。